Search filters

List of works by George Carrum

Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT.

scientific article

Administration of latent membrane protein 2-specific cytotoxic T lymphocytes to patients with relapsed Epstein-Barr virus-positive lymphoma

scientific article published in January 2006

Adoptive transfer of rapidly-generated multivirus-specific T cells to treat Adv, EBV, CMV, BK and HHV6 infections of HSCT recipients

scientific article published on 7 November 2013

CD28 costimulation improves expansion and persistence of chimeric antigen receptor-modified T cells in lymphoma patients

scientific article

Characteristics of T-cell receptor repertoire and myelin-reactive T cells reconstituted from autologous haematopoietic stem-cell grafts in multiple sclerosis

scientific article published on 25 February 2004

Clinical effects of administering leukemia-specific donor T cells to patients with AML/MDS post-allogeneic transplant

scientific article published on 03 December 2020

Clinical responses with T lymphocytes targeting malignancy-associated κ light chains

scientific article published on 06 June 2016

Comparable outcomes of matched-related and alternative donor stem cell transplantation for pediatric severe aplastic anemia

scientific article published in December 2006

Comparison of two CD40-ligand/interleukin-2 vaccines in patients with chronic lymphocytic leukemia ⬇️

scientific article published on July 12, 2011

Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer

scientific article

Cytotoxic T lymphocyte therapy for Epstein-Barr virus+ Hodgkin's disease

scientific article

EBV/LMP-specific T cells maintain remissions of T- and B-cell EBV lymphomas after allogeneic bone marrow transplantation

scientific article published on 27 September 2018

High Incidence of Autoimmune Disease after Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease

scientific article published on 6 April 2018

Immunotherapy of high-risk acute leukemia with a recipient (autologous) vaccine expressing transgenic human CD40L and IL-2 after chemotherapy and allogeneic stem cell transplantation.

scientific article published on 25 October 2005

In Vivo Fate and Activity of Second- versus Third-Generation CD19-Specific CAR-T Cells in B Cell Non-Hodgkin's Lymphomas

scientific article published on 13 September 2018

Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study

scientific article published on 12 September 2013

Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals

scientific article published on 24 September 2006

Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell Transplantation

scientific article published on 7 August 2017

Selective depletion of a minor subpopulation of B-chronic lymphocytic leukemia cells is followed by a delayed but progressive loss of bulk tumor cells and disease regression

scientific article published on 18 November 2009

Successful treatment of stem cell graft failure in pediatric patients using a submyeloablative regimen of campath-1H and fludarabine

scientific article published in November 2008

Sustained complete responses in patients with lymphoma receiving autologous cytotoxic T lymphocytes targeting Epstein-Barr virus latent membrane proteins

scientific article

The safety and clinical effects of administering a multiantigen-targeted T cell therapy to patients with multiple myeloma

scientific article published on 01 July 2020

Tumor-Specific T-Cells Engineered to Overcome Tumor Immune Evasion Induce Clinical Responses in Patients With Relapsed Hodgkin Lymphoma

scientific article published on 9 January 2018

Ultra low-dose IL-2 for GVHD prophylaxis after allogeneic hematopoietic stem cell transplantation mediates expansion of regulatory T cells without diminishing antiviral and antileukemic activity.

scientific article published on 26 February 2014

Paulina is supported by:

About Paulina

Help